XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Stock option activity for the six months ended June 30, 2024 is as follows:
Number of
Shares
Underlying
Outstanding
Options
Weighted-
Average Exercise
Price per Share
Weighted-
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
Outstanding—December 31, 20231,871,649 $7.36 6.72$6,191 
Options exercised(76,860)1.19 
Options cancelled(6,705)16.49 
Outstanding—June 30, 20241,788,084 $7.56 6.19$7,930 
Vested and expected to vest—June 30, 20241,788,084 $7.56 6.19$7,930 
Exercisable—June 30, 20241,659,069 $7.51 6.19$7,421 
Schedule of Stock Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding and exercisable at June 30, 2024.
Options OutstandingOptions
Exercisable
Exercise
Price
Options
Outstanding
Weighted
Average
Remaining
Contractual
Life (Years)
$1.85 212,684 6.02210,786 
2.13 809,709 6.26745,644 
14.22 752,408 6.25689,706 
52.40 13,238 3.6712,933 
1,788,039 1,659,069 
Schedule of Nonvested Restricted Stock Units Activity
A summary of RSU activity is as follows:
Number of
Shares
Weighted Average
Grant Date Fair
Value (per share)
Unvested—December 31, 20233,074,939 $13.19 
Granted2,334,378 9.77 
Canceled(127,957)17.19 
Vested(1,070,815)12.85 
Unvested—June 30, 20244,210,545 $11.26 
Schedule of Nonvested Restricted Stock Awards Activity
A summary of RSA activity is as follows:
Number of
Shares
Weighted Average
Grant Date Fair
Value (per share)
Unvested—December 31, 2023380,383 $15.30 
Granted533,601 7.94 
Canceled— — 
Vested(187,610)12.66 
Unvested—June 30, 2024726,374 $10.58 
Schedule of Stock-based Compensation
The Company recognized stock-based compensation expense for all share-based awards in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Cost of revenue$1,210 $654 $2,123 $1,428 
Research and development4,650 8,204 8,838 15,709 
Sales and marketing1,492 3,500 2,892 6,381 
General and administrative3,343 4,108 6,246 14,728 
Total stock-based compensation$10,695 $16,466 $20,099 $38,246 
The following table summarizes stock-based compensation expense by award type (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
RSUs$7,495 $13,457 $14,304 $29,787 
Stock Options1,512 2,007 3,042 4,012 
Employee stock purchase plan514 224 1,019 408 
RSAs1,174 778 1,734 4,039 
Total stock-based compensation$10,695 $16,466 $20,099 $38,246